Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Turkey flag Turkey · Delayed Price · Currency is TRY
10.25
+0.15 (1.49%)
At close: Mar 5, 2026
-19.54%
Market Cap 2.26B
Revenue (ttm) 739.63M
Net Income (ttm) -312.73M
Shares Out 220.00M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,148,706
Average Volume 2,535,302
Open 10.10
Previous Close 10.10
Day's Range 10.10 - 10.33
52-Week Range 9.60 - 14.32
Beta -0.16
RSI 31.66
Earnings Date Feb 27, 2026

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, rapid antigen test kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, multiplex panel, drug resistance sequencing, food testing kits, as well as sample collection and transport; and full automation, manual magnetic bead nucleic acid extraction, and automated NA extraction instrument kits. The c... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2010
Employees 247
Stock Exchange Istanbul Stock Exchange
Ticker Symbol ANGEN
Full Company Profile

Financial Performance

In 2025, IST:ANGEN's revenue was 739.63 million, an increase of 39.60% compared to the previous year's 529.83 million. Losses were -312.73 million, 42.9% more than in 2024.

Financial Statements

News

There is no news available yet.